{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:50:58Z","timestamp":1791424258554,"version":"4.3.3"},"reference-count":67,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.schres.2016.02.036","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T13:30:51Z","timestamp":1457011851000},"page":"52-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Morphometric analysis of the cerebral expression of ATP-binding cassette transporter protein ABCB1 in chronic schizophrenia: Circumscribed deficits in the habenula"],"prefix":"10.1016","volume":"177","author":[{"given":"Hans-Gert","family":"Bernstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Hildebrandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Dobrowolny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Bogerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Pahnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.schres.2016.02.036_bb0005","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1002\/cne.23167","article-title":"Molecular characterization of the subnuclei in rat habenula","volume":"520","author":"Aizawa","year":"2012","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.schres.2016.02.036_bb0010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jad.2015.04.044","article-title":"IL-6, IL-18, sIL-2R, and TNF\u03b1proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation","volume":"182","author":"Al-Hakeim","year":"2015","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.schres.2016.02.036_bb0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/bies.20706","article-title":"Differential pharmacological regulation of drug efflux and pharmacoresistant schizophrenia","volume":"30","author":"Bebawy","year":"2008","journal-title":"BioEssays"},{"issue":"11","key":"10.1016\/j.schres.2016.02.036_bb0020","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/WNL.0000000000001937","article-title":"Habenula: recently recognized functions and potential clinical relevance","volume":"85","author":"Benarroch","year":"2015","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.schres.2016.02.036_bb0025","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0306-4522(97)00461-2","article-title":"Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics","volume":"83","author":"Bernstein","year":"1998","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.schres.2016.02.036_bb0030","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1023\/A:1007056731551","article-title":"Regional and cellular distribution of neural visinin-like protein immunoreactivities (VILIP-1 and VILIP-3) in human brain","volume":"28","author":"Bernstein","year":"1999","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.schres.2016.02.036_bb0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mad.2014.08.003","article-title":"Vascular and extravascular distribution of the ATP-binding cassette transporters ABCB1 and ABCC1 in aged human brain and pituitary","volume":"141\u2013142","author":"Bernstein","year":"2014","journal-title":"Mech. Ageing Dev."},{"issue":"1","key":"10.1016\/j.schres.2016.02.036_bb0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.schres.2014.03.035","article-title":"Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy","volume":"161","author":"Bernstein","year":"2015","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2016.02.036_bb0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0024-3205(02)01680-6","article-title":"In vitro P-glycoprotein affinity for atypical and conventional antipsychotics","volume":"71","author":"Boulton","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.schres.2016.02.036_bb0050","first-page":"47","article-title":"The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue","volume":"5","author":"Brisch","year":"2014","journal-title":"Front. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2016.02.036_bb0055","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1124\/dmd.111.043083","article-title":"Species comparison of in-vitro P-glycoprotein-mediated brain efflux using mdr1a-deficient rats and mice","volume":"40","author":"Bundgaard","year":"2012","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.schres.2016.02.036_bb0060","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00406-011-0278-3","article-title":"Case\u2013control association study for 10 genes in patients with schizophrenia: influence of 5HTR1A variation rs 10042486 on schizophrenia and response to antipsychotics","volume":"262","author":"Crisafulli","year":"2012","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.schres.2016.02.036_bb0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00318938","article-title":"Tanycytes in the medial habenular nucleus of the rat","volume":"172","author":"Cup\u00e9do","year":"1985","journal-title":"Anat. Embryol. (Berl.)"},{"issue":"1","key":"10.1016\/j.schres.2016.02.036_bb0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00319051","article-title":"Membrane specializations and their relation to HRP transport in the medial habenular nucleus of the rat","volume":"171","author":"Cup\u00e9do","year":"1985","journal-title":"Anat. Embryol. (Berl)"},{"issue":"2","key":"10.1016\/j.schres.2016.02.036_bb0075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pscychresns.2010.05.002","article-title":"Regional increase in P-glycoprotein function in the blood\u2013brain barrier of patients with chronic schizophrenia: a PET study with [(11)C]verapamil as a probe for P-glycoprotein function","volume":"183","author":"De Klerk","year":"2010","journal-title":"Psychiatry Res."},{"issue":"10","key":"10.1016\/j.schres.2016.02.036_bb0080","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.neuropharm.2014.06.017","article-title":"P-glycoprotein activity in the blood\u2013brain barrier is affected by virus-induced neuroinflammation and antipsychotic treatment","volume":"85","author":"Doorduin","year":"2014","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.schres.2016.02.036_bb0085","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/mp.2015.35","article-title":"Kraepelin revisited: schizophrenia from degeneration to failed regeneration","volume":"20","author":"Falkai","year":"2015","journal-title":"Mol. Psychiatry"},{"issue":"403","key":"10.1016\/j.schres.2016.02.036_bb0090","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1749-6632.1995.tb32348.x","article-title":"Interleukin-6 and interleukin-6 receptors mRNA in rat central nervous system","volume":"762","author":"Gradient","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.schres.2016.02.036_bb0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2350-6-7","article-title":"Theories of schizophrenia: a genetic-inflammatory-vascular synthesis","volume":"6","author":"Hanson","year":"2005","journal-title":"BMC Med. Genet."},{"issue":"12","key":"10.1016\/j.schres.2016.02.036_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003964","article-title":"The cerebral microvasculature in schizophrenia: a laser capture microdissection study","volume":"3","author":"Harris","year":"2008","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.schres.2016.02.036_bb0105","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.biopsych.2014.06.020","article-title":"In vivo hippocampal subfield volumes in schizophrenia and bipolar disorder","volume":"77","author":"Haukvik","year":"2015","journal-title":"Biol. Psychiatry"},{"issue":"46","key":"10.1016\/j.schres.2016.02.036_bb0110","doi-asserted-by":"crossref","first-page":"11825","DOI":"10.1523\/JNEUROSCI.3463-08.2008","article-title":"Habenula: crossroad between the basal ganglia and the limbic system","volume":"28","author":"Hikosaka","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.schres.2016.02.036_bb0115","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/484963","article-title":"Bypassing P-glycoprotein drug efflux mechanisms: possible applications in pharmacoresistant schizophrenia therapy","author":"Hoosain","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"12","key":"10.1016\/j.schres.2016.02.036_bb0120","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1211\/jpp.58.12.0008","article-title":"Haloperidol is an inhibitor but not substrate for MDR1\/P-glycoprotein","volume":"58","author":"Iwaki","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"10.1016\/j.schres.2016.02.036_bb0125","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","article-title":"Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment","volume":"2","author":"Khandaker","year":"2015","journal-title":"Lancet Psychiatry"},{"issue":"11","key":"10.1016\/j.schres.2016.02.036_bb0130","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/pmic.201100184","article-title":"Roles of interferon-gamma and its target genes in schizophrenia: proteomics-based reverse genetics from mouse to human","volume":"12","author":"Kim","year":"2012","journal-title":"Proteomics"},{"issue":"1\u20133","key":"10.1016\/j.schres.2016.02.036_bb0135","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.schres.2016.02.007","article-title":"Cortical thinning in bipolar disorder and schizophrenia","volume":"172","author":"Kn\u00f6chel","year":"2016","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2016.02.036_bb0140","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/ejh.12470","article-title":"Can the assessment of ABCB1 gene expression predict its function in vitro?","volume":"95","author":"Kosztyu","year":"2015","journal-title":"Eur. J. Haematol."},{"issue":"4","key":"10.1016\/j.schres.2016.02.036_bb0145","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00401-009-0482-7","article-title":"Microvessel length, total length, and length per neuron in five regions in schizophrenia","volume":"117","author":"Kreczmanski","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.schres.2016.02.036_bb0150","article-title":"Purinergic receptors in psychiatric disorders","author":"Kr\u00fcgel","year":"2015","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.schres.2016.02.036_bb0155","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/tpj.2010.7","article-title":"Asscociation of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia","volume":"11","author":"Kuzman","year":"2011","journal-title":"Pharmacogenetics"},{"issue":"9","key":"10.1016\/j.schres.2016.02.036_bb0160","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1111\/j.0953-816X.2004.03356.x","article-title":"Habenula lesions cause impaired cognitive performance in rats: implications for schizophrenia","volume":"19","author":"Lecourtier","year":"2004","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.schres.2016.02.036_bb0165","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/JCP.0b013e31825ac35c","article-title":"Association study of 27 annotated genes for clozapine pharmacogenetics: validation of preexisting studies and identification of a new candidate gene, ABCB1, for treatment response","volume":"32","author":"Lee","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2016.02.036_bb0170","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.lfs.2015.02.010","article-title":"Angiogenesis in the pathophysiology \u2014 a comprehensive review and conceptual hypothesis","volume":"128","author":"Lopes","year":"2015","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.schres.2016.02.036_bb0175","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1176\/appi.ajp.2013.13020234","article-title":"Microvascular abnormality in schizophrenia as shown by retinal imaging","volume":"170","author":"Meier","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2016.02.036_bb0180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/bs.acr.2014.10.002","article-title":"Regulation of ABC transporters at the blood\u2013brain barrier: the good, the bad, and the ugly","volume":"125","author":"Miller","year":"2015","journal-title":"Adv. Cancer Res."},{"issue":"2","key":"10.1016\/j.schres.2016.02.036_bb0185","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/138920008783571756","article-title":"Genuine functions of P-glycoprotein (ABCB1)","volume":"9","author":"Mizutani","year":"2008","journal-title":"Curr. Drug Metab."},{"issue":"3","key":"10.1016\/j.schres.2016.02.036_bb0190","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0920-9964(94)00045-A","article-title":"Immunoglobulin and albumin content of cerebrospinal fluid in schizophrenic patients: relationship to negative symptomatology","volume":"14","author":"M\u00fcller","year":"1995","journal-title":"Schizophr. Res."},{"issue":"2\u20133","key":"10.1016\/j.schres.2016.02.036_bb0195","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.schres.2015.04.007","article-title":"Brain structure in schizophrenia vs. psychotic bipolar I disorder: a VBM study","volume":"165","author":"Nenadic","year":"2015","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2016.02.036_bb0200","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2174\/156720508785132262","article-title":"Clinico-pathologic function of cerebral ABC transporters \u2014 implications for the pathogenesis of Alzheimer's disease","volume":"5","author":"Pahnke","year":"2008","journal-title":"Curr. Alzheimer Res."},{"issue":"8","key":"10.1016\/j.schres.2016.02.036_bb0205","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.arcmed.2014.10.010","article-title":"Cerebral ABC transporter-common mechanisms may modulate neurodegenerative diseases and depression in elderly subjects","volume":"245","author":"Pahnke","year":"2014","journal-title":"Arch. Med. Res."},{"issue":"2","key":"10.1016\/j.schres.2016.02.036_bb0210","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bbi.2011.11.004","article-title":"Effects of risperidone treatment in adolescence on hippocampal neurogenesis, parvalbumin expression, and vascularization following prenatal immune activation in rats","volume":"26","author":"Piontkewitz","year":"2012","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.schres.2016.02.036_bb0215","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1248\/bpb.29.2446","article-title":"MDR1 gene polymorphisms in Japanese patients with schizophrenia and mood disorders including depression","volume":"29","author":"Qian","year":"2006","journal-title":"Biol. Pharm. Bull."},{"issue":"4","key":"10.1016\/j.schres.2016.02.036_bb0220","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1017\/S0033291709990821","article-title":"Evidence for structural abnormalities of the human habenular complex in affective disorders but not in schizophrenia","volume":"40","author":"Ranft","year":"2010","journal-title":"Psychol. Med."},{"issue":"5","key":"10.1016\/j.schres.2016.02.036_bb0225","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.npp.1300403","article-title":"S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia","volume":"29","author":"Rothermund","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2016.02.036_bb0230","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/00207459208994773","article-title":"Pineal and habenula calcification in schizophrenia","volume":"67","author":"Sandyk","year":"1992","journal-title":"Int. J. Neurosci."},{"issue":"Suppl. 6","key":"10.1016\/j.schres.2016.02.036_bb0235","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1528-1167.2012.03697.x","article-title":"Blood\u2013brain barrier dysfunction in brain diseases: clinical experience","volume":"53","author":"Schoknecht","year":"2012","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.schres.2016.02.036_bb0240","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/schbul\/sbj083","article-title":"Schizophrenia in translation: the presence of absence: habenular regulation of dopamine neurons and the encoding of negative outcomes","volume":"32","author":"Shepard","year":"2006","journal-title":"Schizophr. Bull."},{"issue":"7","key":"10.1016\/j.schres.2016.02.036_bb0245","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1365-2990.2012.01263.x","article-title":"Microvascular changes in late-life schizophrenia and mood disorders: stereological assessment of capillary diameters in anterior cingulate cortex","volume":"38","author":"Sinka","year":"2012","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.schres.2016.02.036_bb0250","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.pnpbp.2012.09.016","article-title":"Immune system and glucose metabolism interaction in schizophrenia: a chicken-egg dilemma","volume":"48","author":"Steiner","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2016.02.036_bb0255","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/schbul\/sbu165","article-title":"Dopaminergic circuitry and risk\/reward decision making: implications for schizophrenia","volume":"41","author":"Stopper","year":"2015","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2016.02.036_bb0260","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/JCP.0b013e31828ecd52","article-title":"Impact of the ABCB1 gene polymorphism on plasma 9-hydroxyrisperidone and active moiety levels in Japanese patients with schizophrenia","volume":"33","author":"Suzuki","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"issue":"8\u201310","key":"10.1016\/j.schres.2016.02.036_bb0265","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.psyneuen.2007.08.001","article-title":"Multidrug-resistance gene 1-type p-glycoprotein (MDR1 p-gp) inhibition by tariquidar impacts on neuroendocrine and behavioral processing of stress","volume":"32","author":"Thoeringer","year":"2007","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1016\/j.schres.2016.02.036_bb0270","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3109\/15622970903414188","article-title":"Ultrastructural damage of capillaries in the neocortex in schizophrenia","volume":"11","author":"Uranova","year":"2010","journal-title":"World J. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2016.02.036_bb0275","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s11307-012-0556-0","article-title":"P-glycoprotein function at the blood\u2013brain barrier: effects of age and gender","volume":"14","author":"Van Assema","year":"2012","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.schres.2016.02.036_bb0280","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fnhum.2014.00174","article-title":"The role of the habenula in drug addiction","volume":"8","author":"Velasquez","year":"2014","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.schres.2016.02.036_bb0285","doi-asserted-by":"crossref","first-page":"15023","DOI":"10.1038\/npjschz.2015.23","article-title":"Microvascular dysfunction in schizophrenia: a case\u2013control study","volume":"1","author":"Vetter","year":"2015","journal-title":"NPJ Schizophr."},{"issue":"10","key":"10.1016\/j.schres.2016.02.036_bb0290","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2217\/pgs.12.86","article-title":"Antipsychotic drug dosage and therapeutic response in schizophrenia is influenced by ABCB1 genotypes: a study from a south Indian perspective","volume":"13","author":"Vijayan","year":"2012","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.schres.2016.02.036_bb0295","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3389\/fnhum.2013.00931","article-title":"The medial habenula: still neglected","volume":"7","author":"Viswanath","year":"2014","journal-title":"Front. Hum. Neurosci."},{"issue":"4","key":"10.1016\/j.schres.2016.02.036_bb0300","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00213-006-0437-9","article-title":"Evaluation of antipsychotic drugs as inhibitors of multidrug resistance tranporter P-glycoprotein","volume":"187","author":"Wang","year":"2006","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.schres.2016.02.036_bb0305","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1038\/tp.2015.69","article-title":"Altered functional connectivity of the cingulate subregions in schizophrenia","volume":"2","author":"Wang","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2016.02.036_bb0310","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1440-1819.2010.02094.x","article-title":"Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models","volume":"64","author":"Watanabe","year":"2010","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2016.02.036_bb0315","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3389\/fnhum.2014.00653","article-title":"A review of structural neuroimaging in schizophrenia: from connectivity to connectomics","volume":"8","author":"Wheeler","year":"2014","journal-title":"Front. Hum. Neurosci."},{"issue":"10","key":"10.1016\/j.schres.2016.02.036_bb0320","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.neurobiolaging.2014.02.016","article-title":"Accelerated white matter aging in schizophrenia: role of white matter blood perfusion","volume":"35","author":"Wright","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"2b","key":"10.1016\/j.schres.2016.02.036_bb0325","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1476-5381.2011.01385.x","article-title":"Influence of ABCB1 genetic polymorphisms on the pharmacoginetics of risperidone in healthy subjects with CYP2D6*10\/*10","volume":"164","author":"Yoo","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"3\u20134","key":"10.1016\/j.schres.2016.02.036_bb0330","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00688048","article-title":"Neuropeptides in the amygdala of controls, schizophrenics and patients suffering from Huntington's chorea: an immunohistochemical study","volume":"71","author":"Zech","year":"1986","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.schres.2016.02.036_bb0335","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.npp.1301181","article-title":"Risperidone and paliperidone inhibit p-glycoprotein activity in vitro","volume":"32","author":"Zhu","year":"2007","journal-title":"Neuropsychopharmacology"}],"updated-by":[{"DOI":"10.1016\/j.schres.2018.03.036","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000}}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996416300901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996416300901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T19:13:44Z","timestamp":1718392424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996416300901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":67,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0920996416300901"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2016.02.036","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.schres.2018.03.036","asserted-by":"object"}]},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Morphometric analysis of the cerebral expression of ATP-binding cassette transporter protein ABCB1 in chronic schizophrenia: Circumscribed deficits in the habenula","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2016.02.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}